We are still accepting applications for Fall 2025 MS MedSLP cohort!

Apply for Fall 2025

Questions? Contact Admissions

Public Notice: Invitation to Comment
For RMU Community and Members of the Public on September 21 at 4 p.m. MT

More Details

MASTER'S

Master of Science in Medical Speech-Language Pathology · MS MedSLP

Residential (First year-3 semesters), Hybrid (Second year-3 semesters) | Full-Time | 24 Months

Connect with Us

Connect with Advisor Attend Info. Session Live Q&A

Welcome to the MS MedSLP Learning Space

Step inside Rocky Mountain University’s Masters of Science in Medical Speech-Language Pathology Clinical Learning Lab through our immersive 360° virtual tour. This interactive experience gives you an inside look at the spaces where students develop hands-on clinical skills, collaborate with faculty, and prepare to provide evidence-based, person-centered care. From simulation and assessment areas to specialized clinical equipment, discover how our innovative learning environment helps prepare future speech-language pathologists for success in a variety of  healthcare settings.

Explore Our Space

Navigate through the tour by clicking on the directional arrows or selecting areas within each scene. You can click and drag to look around in every direction and use the zoom controls for a closer view. Take your time exploring each space to experience the MS MedSLP learning space from every angle.

Program Accreditation

The Master of Science program in Speech-Language Pathology (MS-SLP) residential education program in speech-language pathology, at Rocky Mountain University of Health Professions, is accredited by the Council on Academic Accreditation in Audiology and Speech-Language Pathology of the American Speech-Language-Hearing Association, 2200 Research Boulevard, #310, Rockville, MD 20850, 800-498-2071 or 301-296-5700

The MS MedSLP program to hold a public meeting for accreditation site visit on May 15, 2024 at 5 p.m. For full details for attending and providing public comment, please download the 2024 Public Meeting Notice.